Locatelli, F., Antmen, B., Kang, H. J., Koh, K., Takahashi, Y., Kupesiz, A., Matos, M. G. A. D., Chopra, Y., Bhat, S., Im, H. J., Güngör, T., Lu, M.-Y., Stefanelli, T., Peyrard, S., Smith, Y., Sinclair, K. and Diaz-de-Heredia, C. (2020) “Ruxolitinib in treatment-naive or corticosteroid-refractory pediatric patients with chronic graft-versus-host disease: final analysis of the phase 2 REACH5 trial”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.300144.